- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Paige upgrades series C round to $125m
The computational pathology technology provider has added $25m to a round co-led by Johnson & Johnson Innovation – JJDC.
Mar 10, 2021Edgewise nears $100m IPO
Novo will exit the musculoskeletal disease drug developer, should the latter complete an initial public offering on the Nasdaq Global Market.
Mar 10, 2021Infarm to grow with $100m
The Ideo, Bonnier, JR East, and Demand Analytics-backed urban farm owner has pulled in new equity and debt financing from existing investors.
Mar 10, 2021Design Therapeutics decides to go public
SR One is line for an exit from the small-molecule therapy developer, which has raised $170m in venture funding in the past year.
Mar 10, 2021Neophore negotiates $21m series B
The immuno-oncology company, based on University of Turin research, has completed a $21m series B round led by Claris Ventures.
Mar 10, 2021Quench Bio dismantles business
Max Planck spinout Quench Bio will wind down after its target proved undruggable and will return capital to investors, which include AbbVie Ventures.
Mar 10, 2021Neophore negotiates $21m series B
Astellas Venture Management is among the new investors in the cancer immunotherapy developer, which was spun off by PhoreMost four years ago.
Mar 10, 2021Quench Bio ends operations
Quench Bio will wind down after its protein target proved undruggable and will return capital to investors including AbbVie Ventures.
Mar 10, 2021Xero zeroes in on Planday acquisition
Metro Group is among the shareholders set to exit the employee management platform developer in an acquisition by accounting technology producer Xero.
Mar 9, 2021Innovusion detects $60m
Bertelsmann Asia Investments took part in a round reportedly valuing the lidar technology developer at $300m.
Mar 9, 2021Allianz X adds $75m to WeLab
Allianz will collaborate on the development of new products with the digital financial services provider after supplying it with series C1 funding.
Mar 9, 2021IonQ signs up to $2bn reverse merger
Hyundai, Kia and GV are contributing to a $350 PIPE in support of a reverse merger that will value the Maryland and Duke-linked company at $2bn.
Mar 9, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
